Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Go back to Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701| (NASDAQ: CRBP) | Delayed: 8.31 +0.05 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.26 | 52 Week High | $10.78 | |||
| Open | $8.28 | 52 Week Low | $1.01 | |||
| Day High | $8.62 | P/E | N/A | |||
| Day Low | $8.26 | EPS | $0.00 | |||
| Volume | 296,068 | |||||

